Dabigastran nuevos peligros

Dabigatran users face increased risks for myocardial infarction and acute coronary syndrome (ACS) relative to those on control medications or placebo, according to a meta-analysis in the Archives of Internal Medicine.

revista




Commentators call the results "robust" and "alarming."

A separate editorial note says the findings "deserve serious consideration" when deciding whether to use dabigatran.
editorial